CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network

被引：704
|
作者：
Relling, M. V. [1 ]
Klein, T. E. [2 ]
机构：
[1] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA
[2] Stanford Univ, Dept Genet, Palo Alto, CA 94304 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 89卷 / 03期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1038/clpt.2010.279
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The slow rate at which pharmacogenetic tests are being adopted in clinical practice is partly due to the lack of specific guidelines on how to adjust medications on the basis of the genetic test results. One of the goals of the Clinical Pharmacogenetics Implementation Consortium (CPIC) of the National Institutes of Health's Pharmacogenomics Research Network (http://www.pgrn.org) and the Pharmacogenomics Knowledge Base (PharmGKB, http://www.pharmgkb.org) is to provide peer-reviewed, updated, evidence-based, freely accessible guidelines for gene/drug pairs. These guidelines will facilitate the translation of pharmacogenomic knowledge from bench to bedside.
引用
收藏
页码：464 / 467
页数：4
相关论文
共 50 条
  • [1] Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process
    Caudle, Kelly E.
    Klein, Teri E.
    Hoffman, James M.
    Mueller, Daniel J.
    Whirl-Carrillo, Michelle
    Gong, Li
    McDonagh, Ellen M.
    Sangkuhl, Katrin
    Thorn, Caroline F.
    Schwab, Matthias
    Agundez, Jose A. G.
    Freimuth, Robert R.
    Huser, Vojtech
    Lee, Ming Ta Michael
    Iwuchukwu, Otito F.
    Crews, Kristine R.
    Scott, Stuart A.
    Wadelius, Mia
    Swen, Jesse J.
    Tyndale, Rachel F.
    Stein, C. Michael
    Roden, Dan
    Relling, Mary V.
    Williams, Marc S.
    Johnson, Samuel G.
    [J]. CURRENT DRUG METABOLISM, 2014, 15 (02) : 209 - 217
  • [2] THE CLINICAL PHARMACOGENETICS IMPLEMENTATION CONSORTIUM (CPIC) CLINICAL PRACTICE GUIDELINES
    Caudle, Kelly
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : 1063 - 1064
  • [3] AN UPDATE ON GUIDELINES FROM THE CLINICAL PHARMACOGENETICS IMPLEMENTATION CONSORTIUM (CPIC®)
    Bishop, Jeffrey R.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2018, 57 (10): : S110 - S111
  • [4] Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update
    Johnson, J. A.
    Caudle, K. E.
    Gong, L.
    Whirl-Carrillo, M.
    Stein, C. M.
    Scott, S. A.
    Lee, M. T.
    Gage, B. F.
    Kimmel, S. E.
    Perera, M. A.
    Anderson, J. L.
    Pirmohamed, M.
    Klein, T. E.
    Limdi, N. A.
    Cavallari, L. H.
    Wadelius, M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (03) : 397 - 404
  • [5] Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Ivacaftor Therapy in the Context of CFTR Genotype
    Clancy, J. P.
    Johnson, S. G.
    Yee, S. W.
    McDonagh, E. M.
    Caudle, K. E.
    Klein, T. E.
    Cannavo, M.
    Giacomini, K. M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (06) : 592 - 597
  • [6] The clinical pharmacogenetics implementation consortium (CPIC): facilitating the adoption of pharmacogenetics into routine clinical practice and the electronic health record.
    Caudle, Kelly E.
    Hoffman, James M.
    Whirl-Carrillo, Michelle
    Haidar, Cyrine E.
    Crews, Kristine R.
    Klein, Teri E.
    Relling, Mary V.
    [J]. PHARMACOTHERAPY, 2014, 34 (10): : E251 - E252
  • [7] Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing
    Gammal, R. S.
    Court, M. H.
    Haidar, C. E.
    Iwuchukwu, O. F.
    Gaur, A. H.
    Alvarellos, M.
    Guillemette, C.
    Lennox, J. L.
    Whirl-Carrillo, M.
    Brummel, S. S.
    Ratain, M. J.
    Klein, T. E.
    Schackman, B. R.
    Caudle, K. E.
    Haas, D. W.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (04) : 363 - 369
  • [8] Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
    Caudle, Kelly E.
    Dunnenberger, Henry M.
    Freimuth, Robert R.
    Peterson, Josh F.
    Burlison, Jonathan D.
    Whirl-Carrillo, Michelle
    Scott, Stuart A.
    Rehm, Heidi L.
    Williams, Marc S.
    Klein, Teri E.
    Relling, Mary V.
    Hoffman, James M.
    [J]. GENETICS IN MEDICINE, 2017, 19 (02) : 215 - 223
  • [9] Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update
    Amstutz, Ursula
    Henricks, Linda M.
    Offer, Steven M.
    Barbarino, Julia
    Schellens, Jan H. M.
    Swen, Jesse J.
    Klein, Teri E.
    McLeod, Howard L.
    Caudle, Kelly E.
    Diasio, Robert B.
    Schwab, Matthias
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (02) : 210 - 216
  • [10] Developing knowledge resources to support precision medicine: principles from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
    Hoffman, James M.
    Dunnenberger, Henry M.
    Hicks, J. Kevin
    Caudle, Kelly E.
    Carrillo, Michelle Whirl
    Freimuth, Robert R.
    Williams, Marc S.
    Klein, Teri E.
    Peterson, Josh F.
    [J]. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2016, 23 (04) : 796 - 801
12345